Abstract # 1076 Does the Addition of Bevacizumab to Chemoradiation Prolong Median Survival In Locally Advanced Pancreatic Cancer Patients?

Presenter: Crane, Christopher

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

C. H. Crane*, S. Krishnan*, V. Rana*, H. Q. Xiong*, G. Varadhachary*, S. Palla*, D. B. Evans*, P. Das*, L. Ho*, R. A. Wolff*. , et al., M.D. Anderson Cancer Center, Houston, TX,

Author Disclosure:
C.H. Crane, Genentech, Bristol Meyer Squibb, B. Research Grant; Roche, D. Speakers Bureau/Honoraria; Bristol Meyer Squibb, F. Consultant/Advisory Board; S. Krishnan, None; V. Rana, None; H.Q. Xiong, None; G. Varadhachary, None; S. Palla, None; D.B. Evans, None; P. Das, None; L. Ho, None; R.A. Wolff, None.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout